Published on
02:09 GMT
FDA approves first-of-its-kind RNA drug for hemophilia
The Food and Drug Administration approved on Friday a new type of medicine for people with the rare bleeding disorder hemophilia. Current hemophilia treatments generally try to replace or spur the production of key blood-clotting proteins that are missing …
Source:
BioPharma Dive
-
Label Pending
